Sofgen Pharma S.A. (PROCF)

Sofgen Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	30.32	17.51	43	72.11	4.23
Cash & Short-Term Investments	30.32	17.51	43	72.11	4.23
Cash Growth	73.10%	-59.27%	-40.37%	1605.18%	107.10%
Accounts Receivable	74.35	120.24	98.33	100.05	88.5
Other Receivables	17.43	16.78	19.92	25.34	19.09
Receivables	92.77	139.3	120.57	125.38	107.89
Inventory	76.54	101.83	99.76	81.56	64.28
Other Current Assets	17.11	17.01	15.97	5.84	8.3
Total Current Assets	216.75	275.65	279.3	284.89	184.7
Property, Plant & Equipment	134.07	137.64	112.98	112.81	113.53
Long-Term Investments	2.31	5.87	1.72	2.7	3.22
Goodwill	-	-	5.79	6.8	6.86
Other Intangible Assets	30.31	42.87	32.18	30.13	27.58
Long-Term Deferred Tax Assets	28.26	10.48	7.49	8.47	21.77
Other Long-Term Assets	-	-	3.08	4.53	1.87
Total Assets	411.69	472.5	442.53	450.33	359.54

Liabilities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Accounts Payable	90.19	87.88	87.23	87.36	97.37
Accrued Expenses	25.86	13.78	3.79	-	2.24
Short-Term Debt	4.42	17.41	15.55	-	0.9
Current Portion of Long-Term Debt	254.42	258.69	246.45	224.32	103.62
Current Portion of Leases	6.53	5.44	9.05	-	10.26
Current Income Taxes Payable	6.71	7.82	6.93	12.29	9.39
Other Current Liabilities	27.81	42.54	17.3	32.31	15.85
Total Current Liabilities	415.92	433.57	386.29	356.28	239.63
Long-Term Debt	17.62	1.3	4.03	29.04	313.2
Long-Term Leases	23.79	29.81	25.14	-	26.54
Pension & Post-Retirement Benefits	4.53	4.46	-	-	-
Long-Term Deferred Tax Liabilities	0.69	2.49	6.75	4.95	18.89
Other Long-Term Liabilities	1.23	1.61	57.46	130.05	15.96
Total Liabilities	463.78	473.24	479.66	520.32	614.22

Shareholders' Equity

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Common Stock	1.01	1.01	1.01	1.01	2
Additional Paid-In Capital	392.85	375.49	377.68	377.68	54.41
Retained Earnings	-414.14	-346.05	-386.8	-465.89	-287.45
Comprehensive Income & Other	-30.86	-30.25	-28.09	18.15	-24.42
Total Common Equity	-51.14	0.21	-36.2	-69.05	-255.46
Minority Interest	-0.95	-0.95	-0.94	-0.94	0.78
Shareholders' Equity	-52.09	-0.74	-37.13	-69.99	-254.68
Total Liabilities & Equity	411.69	472.5	442.53	450.33	359.54

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Total Debt	306.77	312.65	300.22	253.37	454.52
Net Cash (Debt)	-276.46	-295.14	-257.21	-181.25	-450.29
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-2.76	-2.92	-2.54	-1.85	-4.64
Filing Date Shares Outstanding	2,327	2,304	112.82	112.82	2
Total Common Shares Outstanding	112.82	112.82	112.82	112.82	2
Working Capital	-199.18	-157.92	-106.99	-71.39	-54.93
Book Value Per Share	-0.45	0.00	-0.32	-0.61	-127.66
Tangible Book Value	-81.45	-42.66	-74.17	-105.99	-289.9
Tangible Book Value Per Share	-0.72	-0.38	-0.66	-0.94	-144.87
Land	40.76	38.53	32.15	30.32	26.82
Machinery	100.04	95.2	61.84	71.23	69.66
Construction In Progress	16.22	23.39	20.72	9.89	9.33

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error